7-259915-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020223.4(FAM20C):​c.1690A>G​(p.Asn564Asp) variant causes a missense change. The variant allele was found at a frequency of 0.458 in 1,534,002 control chromosomes in the GnomAD database, including 164,582 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N564H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.52 ( 21013 hom., cov: 35)
Exomes 𝑓: 0.45 ( 143569 hom. )

Consequence

FAM20C
NM_020223.4 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 4.01

Publications

26 publications found
Variant links:
Genes affected
FAM20C (HGNC:22140): (FAM20C golgi associated secretory pathway kinase) This gene encodes a member of the family of secreted protein kinases. The encoded protein binds calcium and phosphorylates proteins involved in bone mineralization. Mutations in this gene are associated with the autosomal recessive disorder Raine syndrome. [provided by RefSeq, Apr 2014]
FAM20C Gene-Disease associations (from GenCC):
  • lethal osteosclerotic bone dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.8630966E-6).
BP6
Variant 7-259915-A-G is Benign according to our data. Variant chr7-259915-A-G is described in ClinVar as Benign. ClinVar VariationId is 193731.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.66 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAM20CNM_020223.4 linkc.1690A>G p.Asn564Asp missense_variant Exon 10 of 10 ENST00000313766.6 NP_064608.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAM20CENST00000313766.6 linkc.1690A>G p.Asn564Asp missense_variant Exon 10 of 10 1 NM_020223.4 ENSP00000322323.5
FAM20CENST00000515795.1 linkn.1347A>G non_coding_transcript_exon_variant Exon 7 of 7 1

Frequencies

GnomAD3 genomes
AF:
0.515
AC:
78372
AN:
152054
Hom.:
20974
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.666
Gnomad AMI
AF:
0.535
Gnomad AMR
AF:
0.372
Gnomad ASJ
AF:
0.462
Gnomad EAS
AF:
0.506
Gnomad SAS
AF:
0.442
Gnomad FIN
AF:
0.554
Gnomad MID
AF:
0.573
Gnomad NFE
AF:
0.458
Gnomad OTH
AF:
0.498
GnomAD2 exomes
AF:
0.436
AC:
61169
AN:
140220
AF XY:
0.437
show subpopulations
Gnomad AFR exome
AF:
0.672
Gnomad AMR exome
AF:
0.252
Gnomad ASJ exome
AF:
0.458
Gnomad EAS exome
AF:
0.501
Gnomad FIN exome
AF:
0.543
Gnomad NFE exome
AF:
0.457
Gnomad OTH exome
AF:
0.452
GnomAD4 exome
AF:
0.452
AC:
624259
AN:
1381830
Hom.:
143569
Cov.:
66
AF XY:
0.451
AC XY:
307215
AN XY:
681428
show subpopulations
African (AFR)
AF:
0.671
AC:
21158
AN:
31552
American (AMR)
AF:
0.269
AC:
9608
AN:
35654
Ashkenazi Jewish (ASJ)
AF:
0.462
AC:
11604
AN:
25138
East Asian (EAS)
AF:
0.475
AC:
16945
AN:
35638
South Asian (SAS)
AF:
0.436
AC:
34529
AN:
79136
European-Finnish (FIN)
AF:
0.526
AC:
17888
AN:
34036
Middle Eastern (MID)
AF:
0.486
AC:
2750
AN:
5656
European-Non Finnish (NFE)
AF:
0.448
AC:
482762
AN:
1077236
Other (OTH)
AF:
0.468
AC:
27015
AN:
57784
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
20652
41304
61955
82607
103259
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14702
29404
44106
58808
73510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.516
AC:
78462
AN:
152172
Hom.:
21013
Cov.:
35
AF XY:
0.516
AC XY:
38407
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.667
AC:
27694
AN:
41526
American (AMR)
AF:
0.371
AC:
5682
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.462
AC:
1601
AN:
3468
East Asian (EAS)
AF:
0.505
AC:
2606
AN:
5158
South Asian (SAS)
AF:
0.443
AC:
2137
AN:
4824
European-Finnish (FIN)
AF:
0.554
AC:
5863
AN:
10590
Middle Eastern (MID)
AF:
0.582
AC:
170
AN:
292
European-Non Finnish (NFE)
AF:
0.458
AC:
31165
AN:
67986
Other (OTH)
AF:
0.500
AC:
1056
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1992
3984
5975
7967
9959
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
676
1352
2028
2704
3380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.461
Hom.:
20552
Bravo
AF:
0.508
TwinsUK
AF:
0.439
AC:
1626
ALSPAC
AF:
0.430
AC:
1658
ESP6500AA
AF:
0.654
AC:
905
ESP6500EA
AF:
0.443
AC:
1409
ExAC
AF:
0.434
AC:
8679
Asia WGS
AF:
0.498
AC:
1729
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 21, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Asn564Asp in exon 10 of FAM20C: This variant is not expected to have clinical significance because it has been identified in 72.54% (959/1322) of African chro mosomes by the 1000 Genomes Project (Phase 3; dbSNP rs36139924).

Oct 20, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Lethal osteosclerotic bone dysplasia Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
11
DANN
Benign
0.28
DEOGEN2
Benign
0.12
T
Eigen
Benign
-0.96
Eigen_PC
Benign
-0.88
FATHMM_MKL
Benign
0.052
N
LIST_S2
Benign
0.052
T
MetaRNN
Benign
0.0000069
T
MetaSVM
Benign
-0.91
T
PhyloP100
4.0
PrimateAI
Benign
0.48
T
PROVEAN
Benign
0.48
N
REVEL
Benign
0.17
Sift
Benign
0.94
T
Sift4G
Benign
0.94
T
Vest4
0.044
ClinPred
0.0017
T
GERP RS
1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.11
gMVP
0.41
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs36139924; hg19: chr7-299881; COSMIC: COSV58231921; COSMIC: COSV58231921; API